Biocept of Carlsbad, Calif., has appointed Charlotte Clark as its chief business officer and executive vice president. Clark comes to the company, which develops three-dimensional hydrogels for protein, nucleic acid, and cell microarrays, from Myelos, where she served as vice president of business development. Clark has also participated in founding four health care companies, including Nereus Pharmaceuticals and Cygnus.
“Charlotte has a tremendous wealth of knowledge working with start-up biotechnology companies in the business development arena and I have no doubt she will be a great asset to the company,” said Soonkap Hahn, Biocept’s chief operating officer and chief technical officer.
David Allison of the University of Alabama at Birmingham’s department of biostatistics has received a five-year, $409,000 grant from the National Science Foundation to establish a national network of microarray researchers. The network will look at issues in interpretation and use of microarray data. “Our aim is to further explore this technology and in turn, improve its effectiveness,” said Allison. (See article on p.5.)